IS. SECURITY CLASS, (ol Mi raporf) Unclassified ISa. DECLASSIFICATION 30WNGRADING SCHEDULE 16 DISTRIBUTION STATEMENT (ol Ihli ftapon; This report has been distributed in accordance with the distribution list on pages 5 and 6 of the contract, as amended, A copy of the list is included at the end of this report. 17. DISTRIBUTION STATEMENT (ol (ha ab»(rac(anfarad in Sloe* 30, II dlllmrtnt Iran Raporf; 3. SUPPLEMENTARY NO I'iS 'i •' z '-OPr» 'C).n:.vi-ja en r.v.r*. j/d* ft ".-.t^j/v mrj itrt'iy by jlicV rtum'ja/)

The field of electrospray ionization mass spectrometry is reviewed with emphasis placed upon advances in the elucidation of fundamental mechanistic aspects of the ionization process that have been reported over the past 10 years. The analytical consequences of these findings are also examined. Eight central conclusions or 'tenets' are presented, as deduced from the body of work contained in 80 references.where r c is the capillary outer radius, V c is the applied electric potential and d is the distance from the capillary tip to the counter-electrode. The electric field strength is typically ¾10 6 -10 7 V m 1 . 2,3 As ionic species in the sample solution emerge from the ESI capillary, they undergo electrophoretic movement in response to the imposed electric field. In the positive ion mode, anions

Nonadherence to antihypertensive treatment is a critical contributor to suboptimal blood pressure control. There are limited and heterogeneous data on the risk factors for nonadherence because few studies used objective-direct diagnostic methods. We used high-performance liquid chromatography-tandem mass spectrometry of urine and serum to detect nonadherence and explored its association with the main demographic- and therapy-related factors in 1348 patients with hypertension from 2 European countries. The rates of nonadherence to antihypertensive treatment were 41.6% and 31.5% in the UK and Czech populations, respectively. Nonadherence was inversely related to age and male sex. Each increase in the number of antihypertensive medications led to 85% and 77% increase in nonadherence (<0.001) in the UK and Czech populations, respectively. The odds of nonadherence to diuretics were the highest among 5 classes of antihypertensive medications (≤0.005 in both populations). The predictive model for nonadherence, including age, sex, diuretics, and the number of prescribed antihypertensives, showed area under the curves of 0.758 and 0.710 in the UK and Czech populations, respectively. The area under the curves for the UK model tested on the Czech data and for the Czech model tested on UK data were calculated at 0.708 and 0.756, respectively. We demonstrate that the number and class of prescribed antihypertensives are modifiable risk factors for biochemically confirmed nonadherence to blood pressure-lowering therapy. Further development of discriminatory models incorporating these parameters might prove clinically useful in assessment of nonadherence in countries where biochemical analysis is unavailable.